Experimental Headache ModelsJes Olesen, Michael A. Moskowitz Contains papers from the November 1994 Fifth International Headache Research Seminar in Copenhagen, Denmark, plus summaries of articles, in sections on the general use of models in drug development; models currently in use at the preclinical level in migraine research; the use of animal experiments to study the neurobiological basis for pain; the molecular biology of the 5-HT(1D) receptor system; in vivo models; headache models in humans following nitroglycerin or histamine administration; and nonmigrainous headaches. Annotation copyright by Book News, Inc., Portland, OR |
Contents
Models in Early Drug Screening | 11 |
More Advanced Experimental Models for Drug | 19 |
General Characteristics of Clinical Surrogates | 27 |
Copyright | |
41 other sections not shown
Common terms and phrases
action activity afferent agonist animals antagonist arteries arteriovenous associated attacks binding block blood flow blood vessels brain c-fos carotid cause cells central cerebral changes clinical compound concentration contraction cranial decrease Department DISCUSSION dorsal horn dose drug dura dural effect evidence experimental experiments expression extravasation fibers functional gene head human important increase indicate induced infusion inhibition involved Italy laminae levels mean measured mechanisms mediated meningeal method migraine attacks migraine headache minutes Moskowitz muscle nerve Neurology neurons Neurosci nucleus observed Olesen oxide pain patients peptide peripheral Pharmacol Pharmacology plasma possible potential present pressure produced receptor reduced REFERENCES region release Research response role selective sensitivity sensory serotonin showed shown significant similar sinus somatostatin spinal cord spreading depression stimulation subjects substance suggest sumatriptan Table tion tissue treatment trigeminal University values vascular vessels visceral